• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidine carboxylic acids and derivatives Pyrrolidine carboxylic acids

Professional Introduction to Tert-butyl (2S)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate (CAS No. 1630815-56-3)

Ter-butyl (2S)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate, a compound with the CAS number 1630815-56-3, represents a significant advancement in the field of chiral chemistry and pharmaceutical research. This compound, characterized by its complex stereochemical configuration, has garnered considerable attention due to its potential applications in the development of novel therapeutic agents. The unique structural features of this molecule, particularly its tert-butyl substituent and the presence of an (2S)-configuration, make it a promising candidate for further investigation in drug discovery and molecular recognition.

The synthesis and characterization of this compound have been influenced by the latest advancements in synthetic methodologies and analytical techniques. The use of asymmetric synthesis strategies has enabled the precise control of stereochemistry, which is crucial for the development of enantiomerically pure pharmaceuticals. The tert-butyl group, known for its steric hindrance and stability, contributes to the overall rigidity of the molecule, which can be advantageous in terms of binding affinity and metabolic stability. This feature is particularly relevant in the context of designing small-molecule inhibitors that require robust interactions with biological targets.

In recent years, there has been a growing interest in the development of chiral auxiliaries and ligands that can facilitate asymmetric transformations. The pyrrolidine core of ter-butyl (2S)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate serves as an excellent scaffold for such applications. The presence of an amine group at the 2-position allows for further functionalization, enabling the attachment of various pharmacophores. This flexibility makes the compound a valuable building block for medicinal chemists seeking to design molecules with tailored biological activities.

The pharmacological potential of this compound has been explored through various preclinical studies. Initial investigations have highlighted its interactions with enzymes and receptors involved in critical biological pathways. For instance, studies have demonstrated that derivatives of this compound exhibit inhibitory effects on certain kinases, which are implicated in cancer progression. The precise stereochemistry conferred by the (2S)-configuration appears to be crucial for achieving optimal biological activity, underscoring the importance of chirality in drug design.

The use of computational modeling has further enhanced our understanding of the molecular properties of ter-butyl (2S)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate. Advanced simulation techniques have allowed researchers to predict binding affinities and identify potential binding pockets on biological targets. These insights have guided the optimization process, leading to more effective derivatives with improved pharmacokinetic profiles. The integration of experimental data with computational methods has been instrumental in unraveling the structure-activity relationships associated with this class of compounds.

One notable aspect of ter-butyl (2S)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate is its potential role in developing treatments for neurological disorders. The pyrrolidine scaffold is known to be present in several bioactive molecules that interact with neurotransmitter systems. Preliminary studies suggest that derivatives of this compound may modulate receptor activity, offering a new avenue for therapeutic intervention. The combination of steric bulk from the tert-butyl group and chiral discrimination provided by the amine moiety could lead to highly selective ligands with minimal side effects.

The synthetic pathways employed in producing ter-butyl (2S)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate have been refined to ensure high yields and purity. Transition metal-catalyzed reactions have played a pivotal role in constructing complex stereocenters efficiently. These methodologies align with green chemistry principles, minimizing waste and reducing environmental impact. The scalability of these synthetic routes is also a critical factor, as it enables large-scale production necessary for industrial applications.

The analytical characterization of this compound has been conducted using state-of-the-art techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography. These methods have provided detailed insights into its molecular structure and conformational dynamics. High-resolution NMR spectra have confirmed the stereochemical integrity of the pyrrolidine ring, while MS analyses have verified its molecular weight and fragmentation patterns. X-ray crystallography has further elucidated its three-dimensional structure, revealing key interactions within the molecule.

The future directions for research on ter-butyl (2S)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate are multifaceted. Further exploration into its pharmacological effects will be essential to identify new therapeutic applications. Additionally, investigating its potential as a chiral building block for other bioactive molecules could open up new avenues in drug discovery. Collaborative efforts between synthetic chemists, medicinal chemists, and biologists will be crucial in translating these findings into tangible benefits for human health.

In conclusion, ter-butyl (2S)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate represents a significant advancement in chiral chemistry and pharmaceutical research. Its unique structural features and promising biological activities make it a valuable compound for further investigation. The integration of cutting-edge synthetic methodologies, computational modeling, and analytical techniques has positioned this molecule as a key player in the development of novel therapeutic agents.

• 939793-21-2(tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate)
• 1086398-02-8(Tert-butyl 2,5-diazaspiro[3.4]octane-2-carboxylate)
• 1086398-04-0(tert-Butyl 2,5-diazaspiro[3.4]octane-5-carboxylate)
• 960294-14-8(Tert-Butyl 1,7-diazaspiro[4.5]decane-1-carboxylate)
• 1408057-41-9((2R)-1-Boc-2-methylpyrrolidine-2-methanamine)
• 646055-63-2(tert-butyl 1,7-diazaspiro[4.4]nonane-7-carboxylate)
• 1630815-52-9(tert-butyl (2R)-2-(aminomethyl)-2-propylpyrrolidine-1-carboxylate)
• 885268-47-3(Tert-butyl 1,7-diazaspiro[4,4]nonane-1-carboxylate)
• 1630815-50-7(tert-butyl (2S)-2-(aminomethyl)-2-ethylpyrrolidine-1-carboxylate)
• 1630815-53-0(tert-butyl (2R)-2-(aminomethyl)-2-ethylpyrrolidine-1-carboxylate)